 |
|
Regression of Melanoma Nodules in a Patient Treated With Ranitidine
Tom Smith, MD;
Jeffrey W. Clark, MD;
Martin B. Popp, MD
Arch Intern Med. 1987;147(10):1815.
Abstract
• Human malignant melanoma may regress spontaneously or with immunotherapy, such as Calmette-Guerin bacillus, interferon alfa, interleukin-2, and interleukin-2 plus lymphokine-activated killer cells. Histamine type 2 receptor antagonists can modulate immune function by inhibiting suppressor T-cell induction and activity, and melanoma regressions have been reported after the use of cimetidine with coumarin or interferon alfa. This article describes the complete regression of melanoma nodules in a patient treated with ranitidine hydrochloride, another histamine type 2—receptor antagonist. Ranitidine and cimetidine should be considered to be possibly active immunotherapeutic agents in the design and evaluation of clinical trials.
(Arch Intern Med 1987;147:1815-1816)
Author Affiliations
From the Department of Medicine, Medical College of Virginia, Richmond (Dr Smith); the National Cancer Institute, Biological Response Modifiers Program, Frederick, Md (Dr Clark); and the Department of Surgery, University of Cincinnati Medical Center (Dr Popp).
Footnotes
Accepted for publication July 15, 1987.
Reprint requests to Medical College of Virginia Station, Box 230, Richmond, VA 23298-0001 (Dr Smith).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
Slominski et al.
Physiol. Rev. 2004;84:1155-1228.
ABSTRACT
| FULL TEXT
The human histamine H2 receptor regulates c-jun and c-fos in a differential manner
Wang et al.
Am. J. Physiol. Cell Physiol. 2000;278:C1246-C1255.
ABSTRACT
| FULL TEXT
Novel insights into histamine H2 receptor biology
Del Valle and Gantz
Am. J. Physiol. Gastrointest. Liver Physiol. 1997;273:G987-G996.
ABSTRACT
| FULL TEXT
|
